US approval for laser angioplasty catheters:
This article was originally published in Clinica
The US FDA has approved Spectranetics' new line of single-use catheters for laser coronary angioplasty. The Vitesse Cos catheters are designed to remove plaque from the coronary arteries - in trials they improve debulking efficiency by up to 62% compared with earlier devices, said Colorado Springs, Colarado-based Spectranetics. The PMA means that the company could begin selling the products in the second quarter of 2000.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.